Startups
AposHealth® (previously AposTherapy®) is a global leader in the identification and treatment of gait-related conditions.
The AposHealth®’s foot-worn “Apos3” device is FDA-cleared for treating knee osteoarthritis, to help temporarily reduce knee pain and improve lower extremity function during activities of daily living. It is also a non-FDA cleared wellness device which can help patients live well with other gait-related conditions such as chronic low back and hip pain.
With a mission to advance global health through the power of movement, AposHealth®’s latest business unit AposIQ, combines innovative technology, data science and over a decade of experience in gait modification to determine the optimal way to adjust patients’ gaits over time.
Since 2005, AposHealth® has been making it possible for patients in the US, UK, and Israel, to develop better movement patterns and get back to doing the things they love.
The AposHealth®’s foot-worn “Apos3” device is FDA-cleared for treating knee osteoarthritis, to help temporarily reduce knee pain and improve lower extremity function during activities of daily living. It is also a non-FDA cleared wellness device which can help patients live well with other gait-related conditions such as chronic low back and hip pain.
With a mission to advance global health through the power of movement, AposHealth®’s latest business unit AposIQ, combines innovative technology, data science and over a decade of experience in gait modification to determine the optimal way to adjust patients’ gaits over time.
Since 2005, AposHealth® has been making it possible for patients in the US, UK, and Israel, to develop better movement patterns and get back to doing the things they love.
Overview
Location
United States, New York
Employees
51-200
Phone
+1 855-999-2767
Total raised
$11M
Founded date
2004
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 23, 2025 | New Study Finds Apos® Superior to Traditional Physical Therapy for Chronic Low Back Pain | Apos Treatment Program New Study Finds Apos® Superior to Traditional Physical Therapy for Chronic Low Back Pain NEW YORK, NY, UNITED STATES, January 23, 2025 /EINPresswire.com/ -- A new study published in the Global Spine Journal, one of th... |
| Jan 8, 2025 | AposHealth® Wins 2025 Global Recognition Award for Revolutionary Musculoskeletal Care Innovation | Apos Treatment Program AposHealth wins the 2025 Global Recognition Award for revolutionizing musculoskeletal care with Apos®, a drug-free, patient-centric solution for chronic pain NEW YORK, NY, UNITED STATES, January 8, 2025 /EINPresswire.... |
| Dec 12, 2024 | AposHealth Wins 2024 Global Excellence Award for Best Knee-Pain Relief Device | Apos Treatment Program AposHealth received the 2024 Global Excellence Award for its innovative, non-surgical knee-pain relief solution, Apos®, which transforms lives and reduces costs NEW YORK, NY, UNITED STATES, December 12, 2024 /EINPress... |
| Jun 4, 2024 | Apos® Demonstrates 43% Reduction in Healthcare Utilization and Costs for Patients with Knee and Back Pain | New study shows Apos® treatment reduces healthcare costs by 43% for knee OA & low back pain patients. NEW YORK, NEW YORK, UNITED STATES, June 4, 2024 /EINPresswire.com/ -- A recent study published in the Journal of Healthcare Economics ... |
Reviews 0
FAQ about AposHealth
When was AposHealth founded?
AposHealth was founded in 2004.
How much funding has AposHealth raised?
AposHealth has raised $11M in total across 1 funding round.
What has the press written about AposHealth?
Parsers VC has collected 5 articles mentioning AposHealth, among them “New Study Finds Apos® Superior to Traditional Physical Therapy for Chronic Low Back Pain” (Jan 23, 2025) and “AposHealth® Wins 2025 Global Recognition Award for Revolutionary Musculoskeletal Care Innovation” (Jan 8, 2025).
Is AposHealth still active?
Yes, AposHealth is active; its latest activity on Parsers VC dates from Jun 26, 2025.